Table 1.
Study design and study population of surveys analysed to assess field HRP2-based RDT performance
| Survey | ||||||
|---|---|---|---|---|---|---|
| Angola Huambo | Angola Uíge | Mozambique 2013 | Mozambique 2014 | Haiti | Senegal | |
| Persons sampled | 607 | 647 | 1064 | 1015 | 4350 | 501 |
| Period | 2016, rainy season | 2016, rainy season | 2013, dry season | 2014, dry season | 2014–2015 | 2015 |
| Median age (range) | 14 (< 1–90) | 16 (< 1–90) | 16 (< 1–89) | 11 (< 1–86) | 25 (< 1–99) | 23 (3–77) |
| Population | Febrile and afebrile patients attending health facilities | Febrile and afebrile patients attending health facilities | Community sample | Community sample | Community sample | Febrile patients attending 2 health facilities |
| % RDT-positivea (%) | 11 | 46 | 57 | 68 | 1 | 68 |
| Type of RDT | SD bioline Pf/Pv | SD bioline Pf/Pv | SD bioline Pf | SD bioline Pf | First response Pf | CareStart Pf/Pan |
RDT rapid diagnostic test, HRP2 histidine-rich protein 2
aExcluding Pv-positive only for the Angolan surveys